Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.